FDA warns telehealth companies over compounded GLP-1s The FDA has issued a new batch of warning letters to 25 telehealth companies, accusing them of making false and misleading claims in their marketing Sign up to read this article for free
I'm excited to share a new publication in JAMA Psychiatry, which I had the privilege of leading
Additionally, telehealth companies including Hims & Hers (HIMS) and Ro are also providing lower-cost, off-brand alternatives
This injection is especially helpful when the body cannot absorb vitamins efficiently through oral supplements
It suppresses antidiuretic hormone, increases urinary output, worsens GI symptoms, and impairs the liver fluid regulation processes
But GLP-1 medications arent the only way to treat Type 2 diabetes